|[March 06, 2014]
LEAD PLAINTIFF DEADLINE: The Alexander Firm P.C. Announces Upcoming Lead Plaintiff Deadline of March 17, 2014, Concerning Class Actions Against Aegerion Pharmaceuticals, Inc.
LOS ANGELES --(Business Wire)--
Alexander Firm P.C., A Professional Law Corporation, reminds
investors who purchased or acquired shares of Aegerion Pharmaceuticals,
Inc. ("Aegerion" or the "Company") (NASDAQ: AEGR) between March 15, 2012
and January 9, 2014 (the "Class Period") that the deadline of March 17,
2014, is quickly approaching to move for Lead
Plaintiff in the securities class actions filed on behalf of
investors against the Company and certain of its officers.
Aegerion markets its cholesterol drug Juxtapid in the United States.
Juxtapid is the sole FDA-approved Aegerion product and was approved by
U.S. health regulators in December 2012 to treat patients with
homozygous familial hypercholesterolemia (HoFH), a rare genetic disease
that impairs the function of the receptor responsible for removing LDL-C
or "bad" cholesterol from the blood. The actions allege that Aegerion's
marketng practices during the Class Period were in violation of the
Food, Drug, and Cosmetic Act (FDCA), and that defendants made false and
misleading statements or failed to disclose to Aegerion investors that:
(a) the Company marketed its drugs in violation of the FDCA; and (b) as
a result, the Company faced heightened regulatory scrutiny by the FDA
and other governmental bodies.
On January 10, 2014, the Company received a subpoena from the U.S.
Department of Justice requesting documents regarding its marketing and
sale of Juxtapid. As a result of this news, Aegerion shares declined
$7.98 per share, or nearly 11%, to close at $65.77 per share on January
If you purchased or acquired Aegerion common stock between March 15,
2012 and January 9, 2014, you have until March 17, 2014, to move the
Court to be appointed Lead
Plaintiff. If you believe you have suffered losses in excess of
$100,000, would like to learn
more about these claims, or if you have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Vahn
Alexander, Esq., The Alexander Firm P.C., A Professional Law
Corporation, 1875 Century Park East, Suite 700, Los Angeles, California
90067, by telephone at (310) 407-5335, or by email to firstname.lastname@example.org,
or visit our website at www.alexanderfirmpc.com.
With 20 years of class action and complex litigation experience, The
Alexander Firm is committed to protecting the rights of investors
throughout the Country. This press release may be considered Attorney
Advertising in some jurisdictions.
[ Back To TMCnet.com's Homepage ]